SCHEMBL27768382

SCHEMBL27768382

[CH2]C(C=O)NS(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 5/20 0.40
PSEN2 P49810 5/20 0.40
APH1B Q8WW43 5/20 0.40
NCSTN Q92542 5/20 0.40
APH1A Q96BI3 5/20 0.40
PSENEN Q9NZ42 5/20 0.40
CYP2D6 P10635 4/20 0.40
CYP3A4 P08684 2/20 0.40
NPSR1 Q6W5P4 1/20 0.38
SLC1A3 P43003 2/20 0.37
SLC1A2 P43004 2/20 0.37
MMP2 P08253 3/20 0.37
MMP9 P14780 3/20 0.37
MMP1 P03956 2/20 0.37
MMP13 P45452 2/20 0.37
MMP8 P22894 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
MMP7 P09237 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3937372 0.77 SLC1A3 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13623382 0.73 CA1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6005733 0.70 ACP1 (0.50) NPSR1SLC1A3SLC1A2MMP2MMP9
SCHEMBL12054700 0.70 CA1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL31027115 0.70 CYP1A2 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15880574 0.70 CA1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL3458223 0.70 KIF11 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15761593 0.68 PPARG (0.58) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL17679449 0.67 CA1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29213152 0.67 SMN1; SMN2 (0.49) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101490077-A Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators NOVARTIS AG (CH) 2009-07-22 CN disclosed